Skip to main content

Market Overview

Why PRQR Stock And APOP Stock Are Popping Off Today

Share:
Why PRQR Stock And APOP Stock Are Popping Off Today

ProQR Therapeutics NV (NASDAQ: PRQR) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge initially.

ProQR is a biopharmaceutical company that develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Cellect Biotechnology Ltd - ADR (NASDAQ: APOP) shares are trading higher after the company and Quoin Pharmaceuticals announced a strategic merger.

Cellect is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies.

 

Related Articles (PRQR + APOP)

View Comments and Join the Discussion!

Posted-In: News Penny Stocks Small Cap Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com